IL112257A0 - Treatment of motion sickness - Google Patents

Treatment of motion sickness

Info

Publication number
IL112257A0
IL112257A0 IL11225795A IL11225795A IL112257A0 IL 112257 A0 IL112257 A0 IL 112257A0 IL 11225795 A IL11225795 A IL 11225795A IL 11225795 A IL11225795 A IL 11225795A IL 112257 A0 IL112257 A0 IL 112257A0
Authority
IL
Israel
Prior art keywords
treatment
motion sickness
sickness
motion
Prior art date
Application number
IL11225795A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of IL112257A0 publication Critical patent/IL112257A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11225795A 1994-01-14 1995-01-05 Treatment of motion sickness IL112257A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9400600A GB9400600D0 (en) 1994-01-14 1994-01-14 Treatment of motion seckness

Publications (1)

Publication Number Publication Date
IL112257A0 true IL112257A0 (en) 1995-03-30

Family

ID=10748758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11225795A IL112257A0 (en) 1994-01-14 1995-01-05 Treatment of motion sickness

Country Status (6)

Country Link
AU (1) AU1455395A (xx)
GB (1) GB9400600D0 (xx)
IL (1) IL112257A0 (xx)
TW (1) TW276995B (xx)
WO (1) WO1995019164A1 (xx)
ZA (1) ZA95244B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518953D0 (en) * 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9612710D0 (en) * 1996-06-18 1996-08-21 Pfizer Ltd Method of treatment
GB0207104D0 (en) * 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8816365D0 (en) * 1988-07-08 1988-08-10 Pfizer Ltd Therapeutic agents
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
WO1991017973A1 (en) * 1990-05-18 1991-11-28 Merrell Dow Pharmaceuticals Inc. 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS
GB9121631D0 (en) * 1991-10-11 1991-11-27 Nat Res Dev Pharmaceutical compositions

Also Published As

Publication number Publication date
ZA95244B (en) 1996-07-15
AU1455395A (en) 1995-08-01
GB9400600D0 (en) 1994-03-09
TW276995B (xx) 1996-06-01
WO1995019164A1 (en) 1995-07-20

Similar Documents

Publication Publication Date Title
ZA969520B (en) Use of epinastine for the treatment of pain
GB9500247D0 (en) Treatment of poultry
ZA953256B (en) Skin treatment composition
GB9222260D0 (en) Skin treatment
ZA952121B (en) Skin treatment composition
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
GB9217124D0 (en) Medical treatment
ZA95244B (en) Treatment of motion sickness
GB9419571D0 (en) Treatment of oral infections
GB9408084D0 (en) Medical treatment
GB9405046D0 (en) Skin treatment composition
GB9526264D0 (en) Medical treatment
GB9320912D0 (en) Treatment of motion sickness
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9218773D0 (en) Skin treatment
GB9216360D0 (en) Treatment of blood
GB2307858B (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9403306D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB9204062D0 (en) Medical treatment
GB9222195D0 (en) Medical treatment